Nektar Therapeutics: Alopecia Update And A Look At The Road Ahead For Rezpeg

Core Viewpoint - Nektar Therapeutics is advancing the development of rezpegaldesleukin, showing promising results in treating atopic dermatitis and alopecia areata [1] Group 1: Company Development - Nektar Therapeutics has reported successful outcomes in clinical trials for rezpegaldesleukin, particularly in atopic dermatitis [1] - The company is also focusing on the results from recent trials related to alopecia areata, indicating a broadening of its therapeutic applications [1]